Neuropsychiatric adverse event reporting with GLP-1-based therapies: a post-marketing pharmacovigilance analysis using the WHO global individual case safety report database (VigiBase)

BMC Pharmacology and Toxicology · Published 2026-07-28 · DOI 10.1186/s40360-026-01190-4

Free full text

Authors (7)

Jizhou Liang, Lulong Bo, Xiaoyong Miao, Xiaojing Guo, Jinfang Xu, Jia He, Xiaofei Ye

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Liang, J., Bo, L., Miao, X., et al. (2026). Neuropsychiatric adverse event reporting with GLP-1-based therapies: a post-marketing pharmacovigilance analysis using the WHO global individual case safety report database (VigiBase). BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-026-01190-4

Related articles

• Comparative pharmacokinetics for bioequivalence of pramipexole dihydrochloride extended-release tablets in fasting and fed Chinese healthy volunteers: a randomized, open-label, single-dose, crossover study · BMC Pharmacology and Toxicology · 2026 · Same journal
• The potential mechanisms of LCZ696 for anti-hyperthyroid heart disease: an integrative approach of network pharmacology, molecular docking and in vivo verification · BMC Pharmacology and Toxicology · 2026 · Same journal
• Neuroprotective effects of Urolithin A and B in an intracerebroventricular streptozotocin-induced Alzheimer’s-like model in rats · BMC Pharmacology and Toxicology · 2026 · Same journal
• Assessment of the efficiency of new regenerative gel and spray in experimental model systems · BMC Pharmacology and Toxicology · 2026 · Same journal
• Nanotechnology-based detoxification of profenofos using red blood cell membrane-coated polymeric nanoparticles · BMC Pharmacology and Toxicology · 2026 · Same journal
• Optimizing imatinib sampling strategies through a population approach: a crucial step to model-informed precision dosing validation for point-of-care therapeutic drug monitoring · BMC Pharmacology and Toxicology · 2026 · Same journal
• Liposomal amphotericin B as an antifungal prophylaxis in bilateral lung transplantation: a safety analysis · BMC Pharmacology and Toxicology · 2026 · Same journal
• Computational-experimental repurposing reveals synergistic sorafenib/hydroxychloroquine response in KRAS-mutant breast cancer · BMC Pharmacology and Toxicology · 2026 · Same journal
• In- vitro assessment of the anti- malarial potential of Alpha Onocerin; cytotoxicity and hemolytic effect, multi-stage activity and molecular docking · BMC Pharmacology and Toxicology · 2026 · Same journal
• Clinical effects of lamotrigine combined with duloxetine in the treatment of bipolar depression · BMC Pharmacology and Toxicology · 2026 · Same journal